Implanting a ventricular assist device (VAD), or heart pump, is one way the highly skilled interventional cardiologists and surgeons at Loyola Medicine treat patients with heart failure. A VAD is a mechanical pump that helps support heart function and blood flow.

The objective of the present study was to characterize practical utilization trends and outcomes for intra-aortic balloon pump (IABP) and percutaneous left ventricular assist device (pVAD) in cardiogenic shock at a national level.

Axial flow pumps (right top, blue) unload the LV by direct aspiration of arterial blood from the LV, which is ejected by the pump several centimeters above the aortic valve into systemic circulation.

Mar 1, 2021 · The Impella (Abiomed, Danvers, Massachusetts) is an emerging percutaneous ventricular assist device (pVAD). It is a micro-axial, continuous-flow pump, placed over the aortic or pulmonary valve to support the failing ventricle, with blood flows up to 5.5 l/min.

The blue line represents the pVAD proportion of all cardiogenic shock admissions requiring either pVAD or IABP, and the orange bars represent the annual institutional IABP and pVAD volume. (A) 2008 to 2011.

Jul 29, 2022 · In 2008, the US Food and Drug Administration (FDA) cleared the use of the first Impella device, a percutaneous ventricular assist device (PVAD), for short-term mechanical circulatory support (MCS) in severe left ventricular failure. 1 Subsequently, the PROTECT II study (A Prospective, Multi-Center, Randomized Controlled Trial of the IMPELLA ...

In case of persistent respiratory failure, the Harlequin syndrome classically describes a blue-headed (deoxygenated blood directed to the upper body) and red-legged patient (hyperoxygenated blood to the lower body).

Apr 10, 2012 · Percutaneous VADs (PVADs) allow emergent and effective ventricular unloading while providing sufficient systemic perfusion pressure to reverse end-organ dysfunction.

Impella percutaneous ventricular assist device (pVAD) for the reduction and/or prevention of major adverse effects in patients undergoing high-risk percutaneous coronary intervention ( HRPCI). However, future well-designed comparative

Dec 1, 2020 · Proportion of peripheral ventricular assist device (pVAD) use compared with total intraaortic balloon pump (IABP) and pVAD institutional volume. The blue line represents the pVAD proportion of all cardiogenic shock admissions requiring either pVAD or IABP, and the orange bars represent the annual institutional IABP and pVAD volume. (A) 2008 to ...